Skip to content
healthcare.dev
Get a free key

LISINOPRIL and HYDROCHLOROTHIAZIDE

NDC 51407-564, LISINOPRIL and HYDROCHLOROTHIAZIDE, tablet, from GSMS, Incorporated.

Product NDC
51407-564
Status
Listed
Labeler
GSMS, Incorporated
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076674
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51407-564 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISINOPRIL10 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
51407-564-0551407056405500 TABLET in 1 BOTTLE (51407-564-05)
51407-564-905140705649090 TABLET in 1 BOTTLE (51407-564-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d02a0d38-676a-4e0f-9aa2-0a6c56cd7361

Use it

Look up 51407-564 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51407-564 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51407-564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.